Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent chemoradiation therapy for vulvar squamous cell carcinoma (P2 Study)
jRCTs021180042Completed
- Start
- Nov 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nedaplatin in vulvar squamous cell carcinoma (VSCC). Primary endpoint: Tumor response. Started Nov 2014; status: completed.
02
Drugs
nedaplatin
03
Conditions
vulvar squamous cell carcinoma (VSCC)
Beyond the preview
Go deeper on jRCTs021180042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180042.